VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CGEMCullinan Therapeutics, Inc.
$15.03$924M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCGEMPrice History

CGEM logoCullinan Therapeutics, Inc. (CGEM) Stock Price History

Historical prices from 2021 to 2026

$15.03+0.59  (+4.09%)close Jun 18
Returns
1M
+1.1%
3M
+14.5%
YTD
+48.5%
1Y
+84.2%
3Y
+4.8%
5Y
-10.0%
ATH$59.85Mar 2021-74.9%
ATL$5.68Oct 2025pre-split
Avg Vol (50D)980K/ day
52-Week Range$5.68 — $16.74
LowCurrent: $15.03High

Loading 10-year price history...

CGEM Historical Performance

1 YearTotal Return
+84.2%
Price: +84.2%
3 YearsTotal Return
+15.0%
CAGR: +4.8%
Price: +15.0%
5 YearsTotal Return
-40.9%
CAGR: -10.0%
Price: -40.9%
YTD
+48.5%

CGEM Annual Returns

Year-by-year price performance · 2021–2026

Best+15.0%2024
Worst-48.4%2021
Up years2/6
2021-48.4%
2022-36.0%
2023-4.6%
2024+15.0%
2025-16.5%
2026+53.2%
2021 annual price return
-48.4%
2022 annual price return
-36.0%
2023 annual price return
-4.6%
2024 annual price return
+15.0%
2025 annual price return
-16.5%
2026 annual price return
+53.2%
LessMore
Alpha vs S&P 500
1Y+59.2%
3Y-16.2%
5Y-23.7%

Price returns only.

Download Historical Data

1,368 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

CGEM Stock Price Trajectory (2021–2026)

As of June 22, 2026, Cullinan Therapeutics, Inc. (CGEM) trades at $15.03, representing a +84.2% return over the past year. The stock has delivered a -40.9% total return over five years (-10.0% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $59.85 on March 10, 2021. From this peak, CGEM has corrected -74.9%, currently trading 32% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+122.8% 1Y), KYMR (+94.7% 1Y), and RCUS (+185.7% 1Y), CGEM has underperformed the peer group average. Compare CGEM vs IMVT →

CGEM Historical Price Data · from 2021

Rows 1–50 of 1,368
Date Open High Low Close Volume Change %
2026-06-1814.8015.5614.3415.032.34M+4.09%
2026-06-1713.6415.1413.6314.441.49M+6.57%
2026-06-1613.7013.8113.1713.551.05M-0.44%
2026-06-1513.9814.4913.5213.61841K-0.66%
2026-06-1213.0713.7212.7913.701.31M+5.55%
2026-06-1112.2013.2911.9712.981.17M+7.72%
2026-06-1013.3813.9511.6812.052.08M-8.57%
2026-06-0913.3713.7512.4613.181.36M-0.75%
2026-06-0813.7214.1412.4013.281.69M-1.70%
2026-06-0514.3414.3613.4613.51753K-6.38%
2026-06-0415.0715.8414.3314.43888K-5.13%
2026-06-0315.3515.4615.0115.21776K-0.85%
2026-06-0215.8916.0815.2415.341.28M-5.37%
2026-06-0116.3916.6015.9116.21653K-1.40%
2026-05-2915.1916.7215.1016.441.81M+7.03%
2026-05-2815.3615.7514.8415.36786K-1.03%
2026-05-2715.6316.6815.3515.521.34M+0.39%
2026-05-2614.1515.5214.0015.46941K+11.71%
2026-05-2213.9714.2013.8213.84461K-1.00%
2026-05-2114.2214.2913.8213.98637K-2.44%
2026-05-2014.4015.0014.0914.33983K+1.09%
2026-05-1914.8214.8213.3414.181.18M-4.67%
2026-05-1815.7515.8714.8614.871.93M-5.47%
2026-05-1515.8216.0315.3915.73759K-2.60%
2026-05-1416.5216.5415.8116.15696K-1.10%
2026-05-1316.0016.4815.6816.33907K+1.11%
2026-05-1214.7216.2014.5816.151.62M+9.64%
2026-05-1114.8415.2114.6214.73858K+1.24%
2026-05-0814.6115.2014.3114.55587K-1.15%
2026-05-0714.9314.9314.0914.721.23M-1.80%
2026-05-0614.9015.3014.5514.99574K+0.33%
2026-05-0515.5015.7514.2114.94871K-2.61%
2026-05-0413.6615.8813.6015.341.66M+14.22%
2026-05-0113.2613.6612.8913.43511K+2.91%
2026-04-3012.7013.1412.6413.05291K+1.56%
2026-04-2912.7113.1112.4212.85712K+0.31%
2026-04-2813.4013.6012.6912.81503K-3.32%
2026-04-2713.2214.3213.2013.25584K+0.23%
2026-04-2412.8613.3512.5613.22589K+2.08%
2026-04-2313.8514.0712.8612.95523K-6.43%
2026-04-2214.4114.4313.6313.84472K-2.67%
2026-04-2114.5314.5414.1014.22662K-2.07%
2026-04-2014.8215.0414.3914.52491K-3.59%
2026-04-1715.0015.2014.7715.06835K+2.17%
2026-04-1615.0215.0914.6314.74407K-1.40%
2026-04-1514.4115.0714.4014.95965K+4.18%
2026-04-1414.3014.6514.2114.35873K+0.70%
2026-04-1314.4715.0413.7514.251.11M-1.99%
2026-04-1015.0615.3114.4114.54368K-4.40%
2026-04-0914.8215.2214.8015.21527K+1.67%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CGEM — Frequently Asked Questions

Quick answers to the most common questions about buying CGEM stock.

How has CGEM stock performed recently?

CGEM returned +84.2% over the past year, beating its 5-year annualized CAGR of -10.0%. The stock trades above its 200-day moving average, confirming the uptrend.

What is CGEM's all-time high price?

Cullinan Therapeutics, Inc. reached $59.85 on 2021-03-10. The 52-week high is $16.74. Current 1-year return of +84.2% places the stock closer to historical peaks.

Where can I download CGEM historical price data?

This page provides CGEM daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

457 data points · sampled from 1,368